TAG:
pathologists
2001’s Ten Big Stories Presage Future Direction
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
CEO SUMMARY: During 2001, few labs found themselves under intense pressure to change or react to dramatic events in the healthcare marketplace. Like 2000, this past year was marked by evolutionary progress, not revolutionary change. However, continuing signs indicate that consumers will p…
Tripath Imaging Ready To Roil Pap Test Market
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
CEO SUMMARY: Single-handedly, Cytyc Corporation has built the market for thin-layer Pap smear testing. Executives at TriPath Imaging are now ready to challenge Cytyc’s dominance by offering what they believe is a different value proposition to labs: an automated liquid preparation syste…
Laboratories Worth Watching With Stories as Yet Untold
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
BURIED IN MY FILES are any number of magnificent examples of innovative laboratory and pathology management that have yet to reach print in THE DARK REPORT. The limitation is space, influenced by the need to report on important breaking news. THE DARK REPORT is, by design, a compact and fast-to-read…
New Lab Company Ready To Open In Orlando, FL
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
CEO SUMMARY: Within the next 60 days, a brand-new clinical laboratory company will begin operations in Orlando, Florida. In the short term, it plans to offer routine testing to physicians’ offices. However, the real goal is to create a laboratory organization with integrated information…
“December 17, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
Laboratorians interested in the economic paradoxes that sunk the managed care industry might be interested in a new book, Oxymorons: The Myth of a U.S. Healthcare System. Author J.D. Kleinke provides a lucid analysis of the contradictions in our healthcare system. For example, Kleinke descri…
Largest Hospital Lab JV Making Steady Progress
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
CEO SUMMARY: It’s a daunting task to rationalize and integrate lab testing services among 21 hospitals spread out between Eastern Wisconsin and the south side of Chicago. Since the joint venture was announced April 2000, management initiatives have generated lower costs. But the number …
ProxyMed & Medscape Select Atlas LabWorks™
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
CEO SUMMARY: ProxyMed and MedScape just announced contracts with Atlas Development Corporation. Both companies will integrate Atlas LabWorks™ for electronic test ordering and results reporting into software products they sell to labs and physicians’ offices. Such collaborations again …
Beckman Coulter Positions Itself For Biotech Testing Continuum
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
CEO SUMMARY: Here’s a little-known side to diagnostics giant Beckman Coulter Inc. Its efforts to expand into the fields of biomedical R&D and clinical research is a strategic shift designed to give it early access to promising technology that could be introduced into the clinical di…
Sunquest, Towers Perrin, Aetna, Quest Diagnostics, Roche Diagnostics, Careside
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
SUNQUEST REAFFIRMS LONG-TERM COMMITMENT TO COPATHPLUS PRODUCT EXPECT A FASCINATING competitive battle in the market for anatomic pathology software now that Cerner Corporation is acquiring Dynamic Healthcare Technologies, Inc. (DHT) DHT is the developer an…
“November 26, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
Here’s clear evidence that laboratories will play a big role in healthcare’s future. AMIDEX Funds, Inc. just launched the first index-based mutual fund that focuses on cancer companies. Called “AMIDEX Cancer Innovations and Healthcare Mutual Fund” (symbol: CNCRX), it holds in…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized